- Report
- October 2024
- 70 Pages
France
From €870EUR$950USD£741GBP
- Report
- October 2024
- 70 Pages
Germany
From €870EUR$950USD£741GBP
- Report
- October 2024
- 70 Pages
India
From €870EUR$950USD£741GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €870EUR$950USD£741GBP
- Report
- February 2023
- 183 Pages
From €3160EUR$3,450USD£2,692GBP
- Database
- December 2021
United States
From €2290EUR$2,500USD£1,950GBP
- Report
- October 2021
- 39 Pages
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Report
- March 2025
- 75 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- February 2025
- 86 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- October 2024
- 84 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- October 2024
- 104 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- October 2024
- 93 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- September 2024
- 81 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- July 2024
- 89 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- July 2024
- 97 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- July 2024
- 107 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- July 2024
- 109 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- July 2024
- 114 Pages
Global
From €3500EUR$4,094USD£3,086GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more